Compare BALL & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BALL | COO |
|---|---|---|
| Founded | 1880 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Ophthalmic Goods |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 15.5B |
| IPO Year | N/A | N/A |
| Metric | BALL | COO |
|---|---|---|
| Price | $49.20 | $81.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 11 |
| Target Price | $61.75 | ★ $85.82 |
| AVG Volume (30 Days) | 3.0M | ★ 3.3M |
| Earning Date | 11-04-2025 | 12-04-2025 |
| Dividend Yield | ★ 1.63% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.40 | 1.87 |
| Revenue | ★ $12,694,000,000.00 | $4,092,400,000.00 |
| Revenue This Year | $11.82 | $6.66 |
| Revenue Next Year | $4.19 | $5.54 |
| P/E Ratio | ★ $19.54 | $43.53 |
| Revenue Growth | ★ 7.41 | 5.06 |
| 52 Week Low | $43.51 | $61.78 |
| 52 Week High | $60.71 | $104.47 |
| Indicator | BALL | COO |
|---|---|---|
| Relative Strength Index (RSI) | 53.16 | 72.89 |
| Support Level | $48.26 | $75.25 |
| Resistance Level | $50.03 | $78.69 |
| Average True Range (ATR) | 0.89 | 2.48 |
| MACD | 0.10 | 0.47 |
| Stochastic Oscillator | 59.65 | 55.39 |
Ball is the world's largest metal can manufacturer with market share over 30% in its three main regions (North America, Europe, and South America). The company is focused on increasing capacity amid a wave of new developed-market demand, while also investing in faster-growing emerging-market economies. Ball spun-off its glass jar business in 1993 and is now owned by Newell. The company reports three segments—beverage packaging, North and Central America (48% of 2024 revenue), beverage packaging, EMEA (29%), beverage packaging, South America (17%)—and it generated $12 billion in revenue in 2024.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.